NASDAQ:INM
InMed Pharmaceuticals Inc.
- Stock
Last Close
0.33
21/05 19:15
Market Cap
2.41M
Beta: 1.06
Volume Today
737.39K
Avg: 631.00K
PE Ratio
−0.16
PFCF: −0.24
Jun '13 | Jun '14 | Jun '15 | Jun '16 | Jun '17 | Jun '18 | Jun '19 | Jun '20 | Jun '21 | Jun '22 | Jun '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
asset turnover | 0.09 - | 0.29 244.12% | ||||||||||
cash conversion cycle | 915.29 - | 166.20 81.84% | ||||||||||
cash per share | 0.10 - | 0.17 67.19% | 2.40 1,316.19% | 0.57 76.08% | 47.57 8,178.76% | 116.59 145.10% | 66.35 43.10% | 27.94 57.88% | 27.57 1.35% | 11.09 59.76% | 21.81 96.60% | |
company equity multiplier | -0.12 - | 1.05 1,005.84% | 1.05 0.28% | 1.60 52.50% | 1.05 34.59% | 1.03 1.13% | 1.09 4.95% | 1.34 23.79% | 1.33 1.35% | 1.41 6.23% | 1.17 17.16% | |
days of inventory outstanding | 1.67K - | 215.91 87.04% | ||||||||||
days of payables outstanding | 779.67 - | 72.69 90.68% | ||||||||||
days of sales outstanding | 29.49 - | 22.98 22.07% | ||||||||||
dividend yield | ||||||||||||
ebit per revenue | -12.57 - | -1.98K 15,627.26% | ||||||||||
ebt per ebit | 0.95 - | 1.00 5.39% | 1.00 0.05% | 1.00 0.10% | 1.00 0.01% | 0.99 1.05% | 0.97 1.51% | 0.99 1.88% | 1.03 3.55% | 1.36 32.07% | 0.00 99.93% | |
effective tax rate | 0.05 - | -0.00 102.79% | -0.00 30.61% | -0.00 97.44% | -0.00 451.92% | 0.02 14,550.75% | 0.03 24.79% | -0.00 108.26% | -0.04 1,546.97% | -0.26 631.96% | -0.00 99.36% | |
enterprise value multiple | -0.28 - | -18.13 6,352.11% | -2.86 84.22% | -3.40 18.86% | -7.31 115.00% | -13.90 90.14% | -4.64 66.61% | -4.47 3.70% | -1.46 67.41% | -0.09 93.72% | 0.81 983.44% | |
fixed asset turnover | 1.20 - | 5.72 374.49% | ||||||||||
free cash flow per share | -0.96 - | -15.34 1,495.86% | -28.86 88.08% | -5.30 81.62% | -22.00 314.77% | -20.82 5.35% | -32.38 55.53% | -34.45 6.38% | -36.43 5.76% | -27.86 23.54% | -3.04 89.07% | |
gross profit margin | 0.50 - | 0.34 32.00% | ||||||||||
interest coverage | -4.70K - | -679.64 85.55% | -979.95 44.19% | -38.34K 3,812.55% | -6.95K 81.88% | -97.47 98.60% | -469.59 - | -27.54 94.14% | -142.53 417.63% | |||
inventory turnover | 0.22 - | 1.69 671.38% | ||||||||||
long term debt to capitalization | 0.04 - | 0.03 41.08% | 0.04 64.43% | 0.00 96.79% | ||||||||
net income per ebt | 1 - | 1 0% | 1 0% | 1 0% | 1 0% | 1 0% | 0.97 2.60% | 1.00 2.89% | 1.04 3.31% | 1.26 21.56% | 1.00 20.41% | |
net profit margin | -21.49 - | -1.92 91.06% | ||||||||||
operating cash flow per share | -0.96 - | -15.30 1,490.81% | -28.77 88.11% | -5.29 81.61% | -21.82 312.31% | -20.57 5.69% | -32.25 56.75% | -34.25 6.19% | -36.42 6.36% | -27.79 23.71% | -2.98 89.28% | |
operating cycle | 1.69K - | 238.89 85.91% | ||||||||||
operating profit margin | -12.57 - | -1.98K 15,627.26% | ||||||||||
payables turnover | 0.47 - | 5.02 972.61% | ||||||||||
pretax profit margin | -17.07 - | -1.92 88.76% | ||||||||||
price fair value | -0.39 - | 13.73 3,605.06% | 7.68 44.04% | 7.97 3.70% | 4.86 39.04% | 5.24 7.91% | 4.14 21.06% | 7.85 89.80% | 2.90 63.11% | 0.73 74.94% | 0.19 74.17% | |
receivables turnover | 12.38 - | 15.88 28.32% | ||||||||||
return on assets | -9.17 - | -0.72 92.10% | -2.58 256.65% | -1.51 41.57% | -0.54 64.46% | -0.30 43.42% | -0.65 114.88% | -1.16 77.78% | -1.08 6.89% | -1.83 69.50% | -0.56 69.22% | |
return on capital employed | 1.12 - | -0.76 167.89% | -2.71 257.79% | -2.42 10.81% | -0.56 76.76% | -0.32 43.47% | -0.75 135.07% | -1.50 101.04% | -1.31 12.57% | -1.45 10.30% | -675.43 46,593.42% | |
return on equity | 1.06 - | -0.76 171.55% | -2.71 257.63% | -2.42 10.90% | -0.56 76.75% | -0.31 44.06% | -0.71 125.51% | -1.56 120.08% | -1.43 8.14% | -2.58 80.06% | -0.66 74.50% | |
total debt to capitalization | 0.05 - | 0.04 34.22% | 0.08 127.90% | 0.03 60.97% |
All numbers in USD (except ratios and percentages)